Market Cap 4.34M
Revenue (ttm) 0.00
Net Income (ttm) -10.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 5,300
Avg Vol 66,391
Day's Range N/A - N/A
Shares Out 1.04M
Stochastic %K 27%
Beta 0.74
Analysts Hold
Price Target $12.00

Company Profile

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through the ARRIVE Stu...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 693 8448
Fax: 972 3 693 8447
Address:
16 Abba Hillel Road, Ramat Gan, Israel
madan_shatri
madan_shatri Aug. 28 at 9:22 PM
$GLMD Fot better appreciation of share price, we should be focusing on eoQ4 numbers, unless some meaningful progress happens on its Aramchol portfolio. I mentioned this last year that nothing would be happening until 8 to 14 months and I think we are already 10th month from my post. So more or less eoQ4. Challenge would be to see if SP can hold. Soon cracks will start emerging and low volume algorithms & shorts may start buring SP again. Our 52 wk low is $3.29 . Can we go lower than this, yes ?
0 · Reply
LivermoresGhost
LivermoresGhost Aug. 26 at 4:25 AM
$CVAT $CVAT BUYOUT ALERT: Cavitation Technologies CVAT has execute a buyout for this company at 35 million $. This translate to 11.2c per share, you can finds this on the company SEC filing. The stock right now trades 4.3c, the buyout is for 11.2c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 11.2c Current sp: 4.3c 270% Return on Investment, Tender will start this week!!!! https://in.investing.com/news/stock-market-news/cavitation-technologies-agrees-to-35-million-acquisition-deal-93CH-5559884 Here is the company thats buying Cavitation, they have 20 billion Euros Capital Backing. https://euroguarantee.lu/ $AGMB $GLMD $LXRP $LEXX
0 · Reply
YaKnowImRight
YaKnowImRight Aug. 25 at 7:44 PM
$GLMD CG-100 launch announcement may be any day now! Against 1M shares outstanding, that announcement is going to rip.
1 · Reply
Shakattack31
Shakattack31 Aug. 25 at 7:30 PM
$GLMD nice bounce
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 11:39 PM
$GLMD At the market.
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 11:38 PM
$GLMD Thank you.
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 10:18 PM
$GLMD I was thinking that the CEO was using Galmed as an ATM. Btw. Still do.
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 10:16 PM
$GLMD For example. What is ATM. Ing?
1 · Reply
Lowlyme
Lowlyme Aug. 24 at 7:23 PM
$GLMD I chose my handle, Lowlyme, when I joined ST because that's how I see myself as an "investor". Small relative stake, and even less investor "savvy". Which is why I always learn from everyone else's posts. Thank you for. Glta
0 · Reply
MGAP
MGAP Aug. 24 at 6:58 PM
$GLMD small entry
0 · Reply
Latest News on GLMD
Galmed trading halted, news pending

2026-08-18T23:50:11.000Z - 12 days ago

Galmed trading halted, news pending


Galmed announces restructured acquisition terms for Colospan

2026-06-22T11:27:49.000Z - 2 months ago

Galmed announces restructured acquisition terms for Colospan


Galmed to acquire Colospan in cash and stock deal

2026-06-08T12:27:05.000Z - 2 months ago

Galmed to acquire Colospan in cash and stock deal


Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?

2026-04-09T12:36:46.000Z - 5 months ago

Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?


Galmed granted new Use Patent related to lead compound Aramchol

2025-12-04T13:35:34.000Z - 9 months ago

Galmed granted new Use Patent related to lead compound Aramchol


Galmed issues CEO letter to shareholders

2025-12-01T13:40:19.000Z - 9 months ago

Galmed issues CEO letter to shareholders


Galmed Issues CEO Letter to Shareholders

Dec 1, 2025, 8:30 AM EST - 9 months ago

Galmed Issues CEO Letter to Shareholders


madan_shatri
madan_shatri Aug. 28 at 9:22 PM
$GLMD Fot better appreciation of share price, we should be focusing on eoQ4 numbers, unless some meaningful progress happens on its Aramchol portfolio. I mentioned this last year that nothing would be happening until 8 to 14 months and I think we are already 10th month from my post. So more or less eoQ4. Challenge would be to see if SP can hold. Soon cracks will start emerging and low volume algorithms & shorts may start buring SP again. Our 52 wk low is $3.29 . Can we go lower than this, yes ?
0 · Reply
LivermoresGhost
LivermoresGhost Aug. 26 at 4:25 AM
$CVAT $CVAT BUYOUT ALERT: Cavitation Technologies CVAT has execute a buyout for this company at 35 million $. This translate to 11.2c per share, you can finds this on the company SEC filing. The stock right now trades 4.3c, the buyout is for 11.2c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 11.2c Current sp: 4.3c 270% Return on Investment, Tender will start this week!!!! https://in.investing.com/news/stock-market-news/cavitation-technologies-agrees-to-35-million-acquisition-deal-93CH-5559884 Here is the company thats buying Cavitation, they have 20 billion Euros Capital Backing. https://euroguarantee.lu/ $AGMB $GLMD $LXRP $LEXX
0 · Reply
YaKnowImRight
YaKnowImRight Aug. 25 at 7:44 PM
$GLMD CG-100 launch announcement may be any day now! Against 1M shares outstanding, that announcement is going to rip.
1 · Reply
Shakattack31
Shakattack31 Aug. 25 at 7:30 PM
$GLMD nice bounce
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 11:39 PM
$GLMD At the market.
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 11:38 PM
$GLMD Thank you.
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 10:18 PM
$GLMD I was thinking that the CEO was using Galmed as an ATM. Btw. Still do.
0 · Reply
Lowlyme
Lowlyme Aug. 24 at 10:16 PM
$GLMD For example. What is ATM. Ing?
1 · Reply
Lowlyme
Lowlyme Aug. 24 at 7:23 PM
$GLMD I chose my handle, Lowlyme, when I joined ST because that's how I see myself as an "investor". Small relative stake, and even less investor "savvy". Which is why I always learn from everyone else's posts. Thank you for. Glta
0 · Reply
MGAP
MGAP Aug. 24 at 6:58 PM
$GLMD small entry
0 · Reply
edmark1994
edmark1994 Aug. 24 at 3:20 PM
$GLMD looks like they ATM'ing..
1 · Reply
Lowlyme
Lowlyme Aug. 22 at 10:17 PM
$GLMD I've been thinking. Oh my. Anyway I did some research. (Google) Lol I was wondering if there was a site which gathered all of the press releases by a publicly traded company. Historically. Etc. Apparently, at first blush. No. I think it would be helpful to investors. To see what management was saying in the past. In GLMD's case. For instance. What was Allen saying back in say 2018? Or since. Any comments? Or suggestions? GLTA. LM
2 · Reply
TheTarkioTrader
TheTarkioTrader Aug. 22 at 7:35 PM
$BOXL $CDIO $CVAT $GLMD $TLX The underlying deal is real — it’s in CVAT’s SEC filing — but the “10.8¢ locked in, 270% return” framing leaves out some key details. The offer price isn’t fixed: it’s calculated as Net Price ÷ shares outstanding, and that gets recalculated at a record date 45 business days after the tender offer even opens, so the final per-share number can still move. The deal also isn’t done — EGS needs at least 90% of shares tendered, plus a separate $7M side-deal for Alchemy Beverages has to close too. And this plays out over months, not days, with the offer staying open 60+ business days and another 30+ after final pricing is set. The gap between the 3-6¢ trading price and the 10¢+ deal price isn’t free money sitting on the table — it’s the market pricing in real risk that this doesn’t close cleanly. Legit news, just not the guaranteed windfall it’s being sold as.
0 · Reply
LivermoresGhost
LivermoresGhost Aug. 22 at 7:25 PM
$CVAT Cavitation Technologies has execute a buyout for this company at 35 million $. This translate to 10.8c per share, you can finds this on the company SEC filing. The stock right now trades 3.9c, the buyout is for 10.8c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 10.8c Current sp: 3.9c 270% Return on Investment, Tender will start Monday!!!!!!!!!!!!!!!!!!!!!!! https://www.compuserve.com/pf/story/0022/20260817/9811028.htm $GLMD $CDIO $BOXL $TLX
0 · Reply
Slide3
Slide3 Aug. 21 at 2:33 PM
$GLMD How close is commercial launch in Europe of their colon bypass tube? This sell off mini-panic seems really stupid.
2 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 6:02 PM
$GLMD just expanded its colorectal surgery pipeline — and the feasibility data are clean. Colospan successfully measured colon tissue compliance in all 32 patients, with zero measurement failures or procedure-related technical issues. The platform is designed to provide surgeons with objective, quantitative tissue-quality measurements during surgery. Find more on GLMD here👉 https://www.zacks.com/stock/quote/GLMD?cid=sm-stocktwits-0-quote_overview-oc-39334&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39334
0 · Reply
flychicken1991
flychicken1991 Aug. 20 at 11:04 AM
$GLMD Positive (78%): shares could receive modest upward support because the successful feasibility result reduces some technical-development uncertainty around its Colospan unit, but the absence of commercial or regulatory evidence limits the likely repricing. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/4ad35716d8d1522a?utm_source=stocktwits&utm_medium=story_url
0 · Reply
TwongStocks
TwongStocks Aug. 19 at 10:21 PM
Today's reverse split results: $CISS 1 for 40 Previous close $0.0685, $2.74 split-adjusted Today's high $4.90 Today's close $3.09 🟢Up 12.77% $GLMD 1 for 8 Previous close $0.5602, $4.4816 split-adjusted Today's high $5.85 (premarket) Today's close $4.77 🟢Up 6.44%
0 · Reply
Juggsy
Juggsy Aug. 19 at 8:23 PM
$GLMD no walls here. Could blow the top of one or two big buys come in. momentum traders will find this
0 · Reply
madan_shatri
madan_shatri Aug. 19 at 8:20 PM
$GLMD Shareholders meeting is postponed to Sep 02, 2026
1 · Reply
Shakattack31
Shakattack31 Aug. 19 at 8:02 PM
$GLMD thats 1 out of 10 🚀
0 · Reply
madan_shatri
madan_shatri Aug. 19 at 7:02 PM
$GLMD Lucky that we had a good news this morning alongwith RS. Think what if there was no news ?
0 · Reply